An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735
暂无分享,去创建一个
Paul A. Rejto | Jing Yuan | Keith A. Ching | P. Rejto | K. Ching | A. Pavlícek | J. Christensen | K. Hook | Xianxian Zheng | S. Shi | Joan Q. Cao | Jing Yuan | James G. Christensen | Julie L.C. Kan | Xianxian Zheng | Adam Pavlicek | Jingjing Ye | N. Lee | Maruja Lira | Kenneth E. Hook | Scott J. Garza | Maruja E. Lira | Nathan V. Lee | Joan Cao | Mark Ozeck | Stephanie T. Shi | M. Ozeck | Jingjing Ye | S. Garza | Julie L. C. Kan
[1] M. Loda,et al. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. , 2006, Cancer research.
[2] S. Warner,et al. Tubulin-associated proteins: Aurora and Polo-like kinases as therapeutic targets in cancer , 2008, Current oncology reports.
[3] F. Kaye,et al. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. , 1994, Oncogene.
[4] R. Beijersbergen,et al. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. , 2009, Cancer cell.
[5] Yingdong Zhao,et al. Analysis of Gene Expression Data Using BRB-Array Tools , 2007, Cancer informatics.
[6] S. Robinson,et al. The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo , 2011, Molecular Cancer Therapeutics.
[7] L. Pustilnik,et al. PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy , 2010, Molecular Cancer Therapeutics.
[8] J. Battey,et al. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer , 1985, Nature.
[9] Hong Liu,et al. Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase , 2010, Proceedings of the National Academy of Sciences.
[10] P. Kaestner,et al. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells , 2009, Molecular Cancer Therapeutics.
[11] Oliver Gautschi,et al. Aurora Kinases as Anticancer Drug Targets , 2008, Clinical Cancer Research.
[12] N. Ahmad,et al. Regulation of mitosis via mitotic kinases: new opportunities for cancer management. , 2008, Molecular cancer therapeutics.
[13] C. Cole,et al. COSMIC (Catalogue of Somatic Mutations in Cancer) , 2014 .
[14] Mark A. Hall,et al. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. , 2010, Blood.
[15] J. Battey,et al. Human small-cell lung cancers show amplification and expression of the N-myc gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Schwartz,et al. Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780. , 2009, Molecular biology of the cell.
[17] R. Vibhakar,et al. Inhibition of Aurora Kinase A enhances chemosensitivity of medulloblastoma cell lines , 2010, Pediatric blood & cancer.
[18] Jens C. Streibig,et al. Bioassay analysis using R , 2005 .
[19] F. Schabel,et al. Quantitative evaluation of anticancer agent activity in experimental animals , 1977 .
[20] C. Dang,et al. c-Myc Overexpression Uncouples DNA Replication from Mitosis , 1999, Molecular and Cellular Biology.
[21] R Tibshirani,et al. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification , 2006, Oncogene.
[22] Terence P. Speed,et al. Estimation and assessment of raw copy numbers at the single locus level , 2008, Bioinform..
[23] Jianhua Yang,et al. Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma , 2009, Molecular Cancer Therapeutics.
[24] Stephen S. Taylor,et al. Validating Aurora B as an anti-cancer drug target , 2006, Journal of Cell Science.
[25] Rafael A. Irizarry,et al. A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .
[26] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[27] W. Vainchenker,et al. Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process. , 2010, Blood.
[28] S. Emanuel,et al. The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases. , 2005, Cancer research.
[29] Mathias Schmidt,et al. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[30] J. Minna,et al. Amplification and expression of the c-myc oncogene in human lung cancer cell lines , 1983, Nature.